Muhammad Baghdadi - Institute for Genetic Medicine - Academic lecturer

Muhammad Baghdadi

Institute for Genetic Medicine

Academic lecturer

Sapporo, Hokkaido | Japan

Additional Specialties: Cancer Immunology & Immunotherapy

ORCID logohttps://orcid.org/0000-0002-2347-8889

Muhammad Baghdadi - Institute for Genetic Medicine - Academic lecturer

Muhammad Baghdadi

Introduction

Primary Affiliation: Institute for Genetic Medicine - Sapporo, Hokkaido , Japan

Additional Specialties:

Metrics

29

Publications

103

Profile Views

269

Reads

272

PubMed Central Citations

Top co-authors
Haruka Wada
Haruka Wada

Virginia Polytechnic Institute and State University

13
Ken-Ichiro Seino
Ken-Ichiro Seino

Graduate School of Medicine

11
Masahisa Jinushi
Masahisa Jinushi

Institute for Genetic Medicine

8
Hironori Yoshiyama
Hironori Yoshiyama

Shimane University Faculty of Medicine

6
Hirotoshi Dosaka-Akita
Hirotoshi Dosaka-Akita

Hokkaido University School of Medicine

5
Ichiro Kinoshita
Ichiro Kinoshita

Hokkaido University School of Medicine

4
Hideo Yagita
Hideo Yagita

Juntendo University School of Medicine

4
Shigeki Chiba
Shigeki Chiba

Institute for Genetic Medicine

4
Hiraku Endo
Hiraku Endo

Institute for Genetic Medicine

4
Hirotake Abe
Hirotake Abe

Hokkaido University Graduate School of Medicine

3

Publications

29Publications

269Reads

272PubMed Central Citations

Interleukin-34, a comprehensive review.

J Leukoc Biol 2018 Aug 1. Epub 2018 Aug 1.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
August 2018
4 Reads
4.29 Impact Factor

Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report.

Inflamm Regen 2018 10;38:12. Epub 2018 Jul 10.

1Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-Ku, Kita-15 Nishi-7, Sapporo, 060-0815 Japan.

View Article
July 2018
5 Reads

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.

Inflamm Regen 2018 5;38. Epub 2018 Mar 5.

1Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo, 060-0815 Japan.

View Article
March 2018
2 Reads
1 PubMed Central Citation(source)

High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.

Sci Rep 2018 01 11;8(1):418. Epub 2018 Jan 11.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo, 060-0815, Japan.

View Article
January 2018
9 Reads
4 PubMed Central Citations(source)
5.08 Impact Factor

Interleukin 34, from pathogenesis to clinical applications.

Cytokine 2017 11 5;99:139-147. Epub 2017 Sep 5.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Japan. Electronic address:

View Article
November 2017
20 Reads
4 PubMed Central Citations(source)
2.66 Impact Factor

Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.

Proc Natl Acad Sci U S A 2016 06 25;113(24):E3394-402. Epub 2016 May 25.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo 060-0815, Japan;

View Article
June 2016
15 Reads
8 PubMed Central Citations(source)
9.81 Impact Factor

Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.

Hum Cell 2016 Apr 8;29(2):58-66. Epub 2016 Feb 8.

Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7, Sapporo, 060-0815, Japan.

View Article
April 2016
6 Reads
1 PubMed Central Citation(source)

Induction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival.

PLoS One 2014 30;9(10):e111826. Epub 2014 Oct 30.

Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
December 2015
13 Reads
1 PubMed Central Citation(source)
3.23 Impact Factor

New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.

Transplantation 2015 Nov;99(11):2301-10

1 Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. 2 Department of Renal and Genitourinary Surgery, Graduate school of medicine, Hokkaido University, Sapporo, Japan.

View Article
November 2015
71 Reads
1 PubMed Central Citation(source)
3.83 Impact Factor

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.

Cancer Immunol Immunother 2015 Aug 24;64(8):941-9. Epub 2015 Apr 24.

Institute for Genetic Medicine, Hokkaido University, Kita15 Nishi7, Sapporo, Hokkaido, 060-0815, Japan.

View Article
August 2015
31 Reads
4 PubMed Central Citations(source)
3.94 Impact Factor

Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.

MAbs 2014 30;6(5):1124-32. Epub 2014 Oct 30.

a Division of Immunobiology; Institute for Genetic Medicine ; Hokkaido University ; Sapporo , Japan.

View Article
August 2015
2 Reads
1 PubMed Central Citation(source)
4.56 Impact Factor

Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.

Cancer Res 2014 May 17;74(10):2698-709. Epub 2014 Mar 17.

Authors' Affiliations: Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University; Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Sapporo; and Center for AIDS research, Kumamoto University, Kumamoto, Japan

View Article
May 2014
6 Reads
14 PubMed Central Citations(source)
9.33 Impact Factor

The impact of the TIM gene family on tumor immunity and immunosuppression.

Cell Mol Immunol 2014 Jan 16;11(1):41-8. Epub 2013 Dec 16.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Hokkaido, Japan.

View Article
January 2014
3 Reads
7 PubMed Central Citations(source)
4.11 Impact Factor

TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.

Immunity 2013 Dec 5;39(6):1070-81. Epub 2013 Dec 5.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Sapporo, 060-0815, Japan. Electronic address:

View Article
December 2013
7 Reads
16 PubMed Central Citations(source)
21.56 Impact Factor

Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.

Cancer Immunol Immunother 2013 Apr 10;62(4):629-37. Epub 2012 Nov 10.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-0815, Japan.

View Article
April 2013
6 Reads
16 PubMed Central Citations(source)
3.94 Impact Factor

MFG-E8 regulates the immunogenic potential of dendritic cells primed with necrotic cell-mediated inflammatory signals.

PLoS One 2012 25;7(6):e39607. Epub 2012 Jun 25.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
March 2013
10 Reads
3 PubMed Central Citations(source)
3.23 Impact Factor

Regulation of cancer stem cell activities by tumor-associated macrophages.

Am J Cancer Res 2012 20;2(5):529-39. Epub 2012 Aug 20.

Research Center for Infection-associated cancer, Institute for Genetic Medicine, Hokkaido University Sapporo, Japan.

View Article
October 2012
3 Reads
13 PubMed Central Citations(source)
3.97 Impact Factor

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.

Nat Immunol 2012 Sep 29;13(9):832-42. Epub 2012 Jul 29.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

View Article
September 2012
36 Reads
148 PubMed Central Citations(source)
20.00 Impact Factor

ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3-dependent mechanisms.

Cancer Res 2012 Jan 17;72(1):56-65. Epub 2011 Nov 17.

Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Tokyo, Japan.

View Article
January 2012
3 Reads
6 PubMed Central Citations(source)
9.33 Impact Factor
Top co-authors
Haruka Wada
Haruka Wada

Virginia Polytechnic Institute and State University

13
Ken-Ichiro Seino
Ken-Ichiro Seino

Graduate School of Medicine

11
Masahisa Jinushi
Masahisa Jinushi

Institute for Genetic Medicine

8
Hironori Yoshiyama
Hironori Yoshiyama

Shimane University Faculty of Medicine

6
Hirotoshi Dosaka-Akita
Hirotoshi Dosaka-Akita

Hokkaido University School of Medicine

5
Ichiro Kinoshita
Ichiro Kinoshita

Hokkaido University School of Medicine

4
Hideo Yagita
Hideo Yagita

Juntendo University School of Medicine

4
Shigeki Chiba
Shigeki Chiba

Institute for Genetic Medicine

4
Hiraku Endo
Hiraku Endo

Institute for Genetic Medicine

4
Hirotake Abe
Hirotake Abe

Hokkaido University Graduate School of Medicine

3